$4.77 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 127 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NUVALENT INC | $368,253,000 | -15.6% | 19,341,024 | 0.0% | 7.72% | -9.3% | ||
| INVITAE CORPnote 2.000% 9/0 | $153,337,000 | -23.2% | 163,385,000 | 0.0% | 3.22% | -17.5% | ||
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $130,154,000 | -9.5% | 157,390,000 | 0.0% | 2.73% | -2.7% | ||
| CMAX | CAREMAX INC | $128,861,000 | -20.5% | 16,778,750 | 0.0% | 2.70% | -14.5% | |
| ENVISTA HOLDINGS CORPORATIONnote 2.375% 6/0 | $116,547,000 | +6.7% | 52,500,000 | 0.0% | 2.44% | +14.7% | ||
| NATERA INCnote 2.250% 5/0 | $115,754,000 | -14.4% | 45,000,000 | 0.0% | 2.43% | -8.0% | ||
| OMIC | SINGULAR GENOMICS SYSTEMS IN | $105,335,000 | +3.3% | 9,112,019 | 0.0% | 2.21% | +11.0% | |
| NUVASIVE INCnote 1.000% 6/0 | $96,617,000 | -2.2% | 96,966,000 | 0.0% | 2.03% | +5.1% | ||
| PACIRA BIOSCIENCES INCnote 0.750% 8/0 | $90,486,000 | +3.1% | 81,600,000 | 0.0% | 1.90% | +10.9% | ||
| CNC | CENTENE CORP DEL | $82,713,000 | +32.2% | 1,003,800 | 0.0% | 1.74% | +42.1% | |
| INSULET CORPnote 0.375% 9/0 | $76,356,000 | -5.0% | 57,581,000 | 0.0% | 1.60% | +2.1% | ||
| LRMR | LARIMAR THERAPEUTICS INC | $62,908,000 | -6.4% | 5,830,249 | 0.0% | 1.32% | +0.5% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $60,098,000 | -8.0% | 3,933,137 | 0.0% | 1.26% | -1.0% | |
| BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $58,890,000 | -46.7% | 80,000,000 | 0.0% | 1.24% | -42.7% | ||
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $54,417,000 | +4.4% | 57,791,000 | 0.0% | 1.14% | +12.2% | ||
| MIRM | MIRUM PHARMACEUTICALS INC | $52,362,000 | -19.9% | 3,282,912 | 0.0% | 1.10% | -13.9% | |
| INSMED INCnote 1.750% 1/1 | $51,321,000 | -0.8% | 50,000,000 | 0.0% | 1.08% | +6.6% | ||
| APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $43,542,000 | +22.7% | 28,825,000 | 0.0% | 0.91% | +31.7% | ||
| ATEC | ALPHATEC HLDGS INC | $41,089,000 | -6.2% | 3,594,829 | 0.0% | 0.86% | +0.8% | |
| NOVAVAX INCnote 3.750% 2/0 | $34,424,000 | -20.0% | 25,000,000 | 0.0% | 0.72% | -14.0% | ||
| NUVB | NUVATION BIO INC | $30,406,000 | -14.5% | 3,577,233 | 0.0% | 0.64% | -8.1% | |
| HEALTH CATALYST INCnote 2.500% 4/1 | $21,789,000 | -17.1% | 15,000,000 | 0.0% | 0.46% | -10.9% | ||
| ALEC | ALECTOR INC | $21,790,000 | -9.5% | 1,055,192 | 0.0% | 0.46% | -2.8% | |
| XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1 | $21,577,000 | +14.4% | 18,000,000 | 0.0% | 0.45% | +23.1% | ||
| OM | OUTSET MED INC | $18,465,000 | -6.8% | 400,622 | 0.0% | 0.39% | 0.0% | |
| TERN | TERNS PHARMACEUTICALS INC | $16,586,000 | -32.1% | 2,345,959 | 0.0% | 0.35% | -27.0% | |
| ONCR | ONCORUS INC | $16,595,000 | -43.6% | 3,148,977 | 0.0% | 0.35% | -39.4% | |
| INZY | INOZYME PHARMA INC | $15,991,000 | -41.2% | 2,344,786 | 0.0% | 0.34% | -36.8% | |
| DA32 LIFE SCNCE TEC ACQSTN C | $15,696,000 | -0.2% | 1,600,000 | 0.0% | 0.33% | +7.2% | ||
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $15,326,000 | +1.8% | 14,527,000 | 0.0% | 0.32% | +9.2% | ||
| VINC | VINCERX PHARMA INC | $14,055,000 | -37.0% | 1,379,310 | 0.0% | 0.30% | -32.2% | |
| COGT | COGENT BIOSCIENCES INC | $13,737,000 | +2.0% | 1,601,000 | 0.0% | 0.29% | +9.5% | |
| QSI | QUANTUM SI INC | $11,018,000 | -5.6% | 1,400,000 | 0.0% | 0.23% | +1.3% | |
| MTAC | MEDTECH ACQUISITION CORP | $9,880,000 | -0.5% | 999,999 | 0.0% | 0.21% | +6.7% | |
| REVH | REVOLUTION HEALTHCAR AQ CORP | $9,740,000 | +0.3% | 1,000,000 | 0.0% | 0.20% | +7.4% | |
| SNRH | SENIOR CONNECT ACQUISITN COR | $9,740,000 | -0.3% | 1,000,000 | 0.0% | 0.20% | +6.8% | |
| GRAY | GRAYBUG VISION INC | $9,666,000 | -44.9% | 5,281,713 | 0.0% | 0.20% | -40.6% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $9,173,000 | -42.6% | 6,949,416 | 0.0% | 0.19% | -38.5% | |
| AFIB | ACUTUS MED INC | $9,031,000 | -61.4% | 2,648,386 | 0.0% | 0.19% | -58.6% | |
| PRVA | PRIVIA HEALTH GROUP INC | $7,761,000 | +9.8% | 300,000 | 0.0% | 0.16% | +18.1% | |
| IGNY | IGNYTE ACQUISITION CORP | $7,062,000 | -0.5% | 725,000 | 0.0% | 0.15% | +6.5% | |
| DEFINITIVE HEALTHCARE CORP | $6,833,000 | -36.2% | 250,000 | 0.0% | 0.14% | -31.6% | ||
| ANNX | ANNEXON INC | $6,709,000 | -38.3% | 583,913 | 0.0% | 0.14% | -33.5% | |
| AMWL | AMERICAN WELL CORPcl a | $5,986,000 | -33.7% | 991,115 | 0.0% | 0.13% | -28.4% | |
| OHPA | ORION ACQUISITION CORP | $4,890,000 | +0.8% | 500,000 | 0.0% | 0.10% | +8.4% | |
| DCTH | DELCATH SYS INC | $3,875,000 | -25.8% | 500,000 | 0.0% | 0.08% | -20.6% | |
| NEOGENOMICS INCnote 0.250% 1/1 | $2,132,000 | -15.2% | 2,500,000 | 0.0% | 0.04% | -8.2% | ||
| CABA | CABALETTA BIO INC | $1,760,000 | -68.8% | 464,252 | 0.0% | 0.04% | -66.4% | |
| MDVL | MEDAVAIL HOLDINGS INC | $1,600,000 | -52.0% | 1,142,552 | 0.0% | 0.03% | -47.7% | |
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $931,000 | -53.8% | 733,333 | 0.0% | 0.02% | -48.7% | |
| CMAXW | CAREMAX INC*w exp 06/08/202 | $941,000 | -50.5% | 672,000 | 0.0% | 0.02% | -45.9% | |
| QSIAW | QUANTUM SI INC*w exp 06/10/202 | $600,000 | -11.4% | 333,333 | 0.0% | 0.01% | 0.0% | |
| SOMALOGIC INC*w exp 08/31/202 | $401,000 | -3.1% | 120,000 | 0.0% | 0.01% | 0.0% | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $315,000 | -26.2% | 166,666 | 0.0% | 0.01% | -12.5% | |
| SNRHW | SENIOR CONNECT ACQUISITN COR*w exp 12/31/202 | $263,000 | -25.9% | 500,000 | 0.0% | 0.01% | -14.3% | |
| IGNYW | IGNYTE ACQUISITION CORP*w exp 01/05/202 | $279,000 | +20.3% | 362,500 | 0.0% | 0.01% | +20.0% | |
| SURROZEN INC*w exp 08/01/203 | $192,000 | +1.1% | 166,666 | 0.0% | 0.00% | 0.0% | ||
| MTACW | MEDTECH ACQUISITION CORP*w exp 12/22/202 | $174,000 | -36.3% | 333,333 | 0.0% | 0.00% | -20.0% | |
| REVHW | REVOLUTION HEALTHCAR AQ CORP*w exp 12/31/202 | $150,000 | -19.4% | 200,000 | 0.0% | 0.00% | -25.0% | |
| OHPAW | ORION ACQUISITION CORP*w exp 02/19/202 | $81,000 | +1.2% | 125,000 | 0.0% | 0.00% | 0.0% | |
| WINT | WINDTREE THERAPEUTICS INC | $32,000 | -23.8% | 20,148 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.